Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations

Extended projects support ongoing research into computational approaches and new approach methodologies for food and chemical safety assessment

SLP : 13.97 (-0.92%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 8, 2026 /PRNewswire/ --

SLP : 13.97 (-0.92%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 3, 2026 /PRNewswire/ --

SLP : 13.97 (-0.92%)
Simulations Plus to Participate in Upcoming Investor Conferences

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced...

SLP : 13.97 (-0.92%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Jan. 29, 2026 /PRNewswire/ --

SLP : 13.97 (-0.92%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Jan. 23, 2026 /PRNewswire/ --

SLP : 13.97 (-0.92%)
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day

Showcases platform momentum, strategic priorities, and long-term value creation outlook

SLP : 13.97 (-0.92%)
Simulations Plus: Fiscal Q1 Earnings Snapshot

Simulations Plus: Fiscal Q1 Earnings Snapshot

SLP : 13.97 (-0.92%)
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results

Investor Day on January 21, 2026, to present new product vision and AI solutions

SLP : 13.97 (-0.92%)
Simulations Plus in Minus Category on Word of Investor Day in January

Simulations Plus, Inc. (NASDAQ: SLP) shares lost ground Thursday. The company, a global leader in model-informed ...

SLP : 13.97 (-0.92%)

Barchart Exclusives

This Is the Top-Rated Dividend Stock to Buy in February 2026
CMCL’s low payout ratio, hedged $3,500‑floor gold pricing, and 56% implied upside from its lone “Strong Buy” target make it an attractive small‑cap dividend grower for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar